Altering Multitasking Behavior Using Low Current Brain Stimulation
NCT ID: NCT03873636
Last Updated: 2025-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
300 participants
INTERVENTIONAL
2016-12-27
2025-04-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Stimulation Study
NCT02067689
Effect of Noninvasive Electrical Brain Stimulation on Memory at Different Times of Day in Younger and Older Adults
NCT03723850
The Short-term Effects of Noninvasive Electrical Brain Stimulation on Dual Tasking in Older Adults
NCT03191812
Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's Disease
NCT01847586
The Effects of Noninvasive Brain Stimulation on Physical and Mental Functioning in Older Adults
NCT02436915
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Stimulation
Active stimulation of targeted brain regions involved in task-switching and dual-tasking.
Stimulation via noninvasive brain stimulation systems
Active (at or below 2mA) stimulation targeting brain regions engaged in task-switching and dual-tasking for 30-40 minutes. Local IRB has determined the Soterix, Neuroelectrics, \& Halo devices to be non-significant risk (NSR) devices via abbreviated investigational device exemption (IDE) procedure.
Sham Stimulation
Sham stimulation of targeted brain regions involved in task-switching and dual-tasking.
Stimulation via noninvasive brain stimulation systems
Active (at or below 2mA) stimulation targeting brain regions engaged in task-switching and dual-tasking for 30-40 minutes. Local IRB has determined the Soterix, Neuroelectrics, \& Halo devices to be non-significant risk (NSR) devices via abbreviated investigational device exemption (IDE) procedure.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stimulation via noninvasive brain stimulation systems
Active (at or below 2mA) stimulation targeting brain regions engaged in task-switching and dual-tasking for 30-40 minutes. Local IRB has determined the Soterix, Neuroelectrics, \& Halo devices to be non-significant risk (NSR) devices via abbreviated investigational device exemption (IDE) procedure.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be a fluent English speaker
* Must be at least 18 years old
* Must be right-handed
* Must have normal or corrected-to-normal vision
Exclusion Criteria
* Any metallic implants in head
* Any implanted internal or external electrical stimulation device
* Any adverse reaction to tDCS or other forms of low current brain stimulation
* Any history of seizure
* Any history of head injury
* Any illness that caused brain injury
* Any other brain-related condition
* Any diagnosis of neurological or psychiatric disorder
* A sensitive scalp
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tufts University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nathan Ward
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nathan Ward, PhD
Role: PRINCIPAL_INVESTIGATOR
Tufts University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tufts University
Medford, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1611020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.